|
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
|||
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of Each Class
|
Trading
Symbol(s)
|
Name of Exchange
on Which Registered
|
||
|
|
The
|
Item 3.03
|
Material Modifications to Rights of Security Holders.
|
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
|
3.1
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Dated: April 19, 2024 | Windtree Therapeutics, Inc. | |
By: | /s/ Craig E. Fraser | |
Name: Craig E. Fraser | ||
Title: President and Chief Executive Officer |
Exhibit 3.1
CERTIFICATE OF AMENDMENT TO
THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
WINDTREE THERAPEUTICS, INC.
(Pursuant to Sections 228 and 242 of the
General Corporation Law of the State of Delaware)
The Company was originally incorporated on November 6, 1992, under the name “Ansan, Inc.” The Company changed its name on November 25, 1997, to Discovery Laboratories, Inc. The Company changed its name again on April 15, 2016, to Windtree Therapeutics, Inc.
This Certificate of Amendment to the Amended and Restated Certificate of Incorporation was duly adopted in accordance with Sections 228 and 242 of the General Corporation Law of the State of Delaware (“Delaware Corporation Law”) and the amendments set forth below shall become effective upon the filing and effectiveness pursuant to the Delaware Corporation Law of this of Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company:
1. Article Four of the Amended and Restated Certificate of Incorporation of the Company is hereby amended by adding the following paragraph at the end thereof:
“Upon the filing and effectiveness (the “Third Effective Time”) pursuant to the Delaware Corporation Law of this Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Corporation, as amended, each eighteen (18) shares of the Corporation’s common stock, par value $0.001 per share (the “Common Stock”), issued and outstanding immediately prior to the Third Effective Time shall automatically be combined into one (1) validly issued, fully paid and non-assessable share of Common Stock without any further action by the Corporation or the holder thereof (the “Third Reverse Stock Split”). No fractional shares will be issued as a result of the Third Reverse Stock Split. Each certificate that immediately prior to the Third Effective Time represented shares of Common Stock (“Third Old Certificates”), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Third Old Certificate shall have been combined. Holders who otherwise would be entitled to receive fractional share interests of Common Stock upon the effectiveness of the Third Reverse Stock Split shall be entitled to receive a whole share of Common Stock in lieu of any fractional share created as a result of the Third Reverse Stock Split.”
2. This Certificate of Amendment shall become effective on April 19, 2024 at 11:59 p.m. Eastern Time.
3. Except as set forth in this Certificate of Amendment, the Amended and Restated Certificate of Incorporation, as amended, remains in full force and effect.
[Rest of Page Left Blank]
IN WITNESS WHEREOF, Windtree Therapeutics, Inc. has caused this Certificate of Amendment to be signed by its duly authorized officer this 19th day of April, 2024.
WINDTREE THERAPEUTICS, INC. |
|||
By: |
/s/ Craig E. Fraser | ||
Craig E. Fraser President and Chief Executive Officer |
Document And Entity Information |
Apr. 19, 2024 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | Windtree Therapeutics, Inc. |
Document, Type | 8-K |
Document, Period End Date | Apr. 19, 2024 |
Current Fiscal Year End Date | --12-31 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 001-39290 |
Entity, Tax Identification Number | 94-3171943 |
Entity, Address, Address Line One | 2600 Kelly Road, Suite 100 |
Entity, Address, City or Town | Warrington |
Entity, Address, State or Province | PA |
Entity, Address, Postal Zip Code | 18976 |
City Area Code | 215 |
Local Phone Number | 488-9300 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | WINT |
Security Exchange Name | NASDAQ |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0000946486 |
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end
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
@B8<(UR&63>L9O+FO&T.J[.B;]*23IO.4\G1 -CR)B';G$R5 MK#Q60'"1>QGYS2K&VP65>'LXUR.E1NKQA@I.O1 $ F(,]W!"Q8A[+6PN'?_^ MJ[5O'J;SC$4RS9CQT3@$;0QN09U\%[7I5U/].R0#:E^/!-A>QUALFG(G'*,2 MF[]!/U\ 'EK5#DD\,:D%(3&5R*Q :P&K+%*-%4@A/0WJ\I'7LH'+3.31/!H< M_WEYWN^J,0 M5[-,+O3C=DG@FK%*0MVX2_)ZZAVB$,JH.X8"O, 1F\U[ND!"V*K\$9)LC=0Z MIQ2426"TINO5X:V851<45QFW9Y5S6/;*G=**V4* )'$CE5?+")7U,>*%SIPQ M07M/8M\+_\0>T]NA++2F(W1PIDV1\:*4&$GF9GQ1JB?4$ D)@S MC_)'+U(YHRALK_5A'LK..O$(O;,B2=O >E$C(535QJ )NM0'-@.6S#X&7/BO M W/*V;(#@=X3E<[:RR*%R+8 4>#9\DO& MN3Y DAT]T28&F2)9H99>YGW2$8=/; AO^J<:VLB/>.0=S;I#)+6 6)_!*TE?;B@LJ";\(Q[9@K1NE/6D=95! SX&]0HY48)N55C5! 5ZJEE MPRC=.)YC5LLNVE,^9IH=6.O623/XWSA(K[/:1R4"FAEML#\7 ]VR?3H:$JY\ M!TL74G>DV8(Q[8Z$!,$8M4]_&OV,5O1VQQJ==%!%$R,%'S)/_N?18!F-0#6S M4+;7+'4.PWB=4S*4LEDMKUHK*!7!Z)U\M_"G0A^L>7.B*&S/.WH3ROCL,>-$ M*U+[+TX4*@A5I3&X87@78381UOO*X(U/Q0@S\^A2NV-8&+W7EJ$2T=:>X8H< MI>PHHV]@R[!86*BIF!&_W(AI1R"G'O>A-U$X1-E>TQ,Y#-,N6),AR6:UZ&JM MH%0$@QU!1Q R+^R*">7B-ZSO C1Q>]W\6UBV;ON,%B6\2! W<,/K9(3*^NQX M8>,B>N+H^OTGDO[WLOCE/U!+ P04 " " 5B8Q8(T3HR].@7^_G\-EJ8@35RLCU2_DXA/[^/AS\OF8CY^W M"?=>*&1,I'V_U6CZ'DTC$;-TV?>_3X/!=#@:^5XF21H3+E+:]U/A?_[T\T\? M?PF"+S2E0"2-O?G.FZWR-*9P)Q+J301(PKW NPE;W;#=;-]X'WJWS1X>)X]! MH![G+/W14S]SDE$/::19<=GW5U*N>V&XV6P:VSGPAH E5M'LA$>T?X"KTEB> M'C@'WX;[PA/THNI-I\"VNMUN6)2>H!DK V*EK?#/Q_$T6M&$!"Q5FD2*2\9Z M67%S+"(B"R%KN^!I$>HJ.,("=2MHM8-.J['-8O\D' A.G^G"4\?OSZ/7A%DJ M&Y%("MV;-S@ "A4B7TD3FLH@%E%>G."@!GAD U M!<>:%(E?WUR1W*TQ;C*6K#GUPU,?UD S?*B CO'& :W(6NG/G@;=2HIQ>J8E M%]&K'JNFLV,\931J+,5+&%.FVN^H$R5'IY "+_ZY+QK$L"?LU!0G<\K[OJYX MSX2K(L<1OF -CD \LBPO^B M!/3TZJ"6&.XGWS-=LDP"2>4WDI2QJX)993;"KS^L!13!/56OV*'(4PF[H8CU M1(V>LLK[@7'Z+4_F%+0D+R%6& *M/H$,['1?VRUR&OP*Z+_"28@7M@^/ZPDJ8%?@^E$8 K%_V;K MRJE=!;;U%E?- B4:7F7%MC(JK)!/5KCNT4Y>'<02HS^ 24Q@AR))\O3PHBA+ M52IQEKA-!6<1D[AV?,2@!D9X"3$]R!*K"5"E BYKB]7"3&7_\+18E(YF/?@Z M+$=9EE-X$U?M([9&FT8Y!MFNU9[/F"S-ZG402XQF0)1Q,=TEJ7EEM6Y MWT8KDBZI)L^K@EG]!MPG%)8HQA<0&[G".%J3=*?]"%2B+?$<8%#'*K ?.%F6 M,"LMMZK9$!L#PD ;OH OPSFCLE1$X<"X[*GPG1U;Z3&^XH/K1IZ M[\I(A;9;*E38949R=-R0P\R>,U+DQ@U%WNRT&8ESZY(X.H?/2(G?7%+"R$PT MDN5WEV2I]2Z-)/G@H"0ZL]1(D*Z#@E0:LV;IF5/9:KT/;":*(TFKWH0VD\&1 MK+7:_3:3PI&,U28,4_/IU*U(_Z.S;>^1=02P,$% @ G(:36*/ZU;)W% GG\ !, M !W:6YT,C R-# T,3=?.&LN:'1M[3UM<]JXNI^WOT*'O;M-9V*P@21 TIQ) M">GFMDDSP,[NO5_."%N 3HSM2G8(Y]>?YY%L8X,)(4U*DZ:S.\%(EI[W-[UP M],_;B4MNF)#<]]Z_M X-WK_]J37/C]_^\_C-T?C$+I!5T^^+XW# M,&A5*M/IM#RME7TQJEC-9K-RBWU*NE-+L&&NX^U N*IKU33W*]":=,0&AZ=] M\_UT8]+5H]R6^9Z2V>61?U-13?!.M98=EZ\$H5;AG@RI9[.TOW2*,(.^5N7O MB\\]>\PF-.G,;T,#ILZ]D(#"/9=[[.\/W<^54%!/#GTQH2%0%\:R]@RS8=2L M=%+H>KV:H-B:F;(8FW7S58WJ?DI!W_.B2?$X3B@JX2Q@%>AD0"\FN)V\%TD# MF^;$'U(Y4&\E+3G:1Z%@HY6T;U:@?8[6JGY6+8-:!A#ANRL 42T(B&F85H;* M,@Q$L=A@2P[R)7[DA0:;!U2F0L.E7Z]:!W>)F>Z1O !$7J!D,0\2)*I63D_" M0CW9TWH2SD69KQ=E8U$!PG'D.4PX_H3EWNZ>?CSC@/A(EFU_DF'Q_1A\6V@P MUL#B,%[,,&C(2YHT1I0&A>* #;G.MA]YH9@5CQPWYEX0*\1&H-!8C04IX_8* M(>-V'HQ("#"QJ^"(6W.OL%M[7-P=6W)=I0B7J0%?YCI-N9>W)O@%LA=[U 7XJ*)A/!KXSHS(<.:"Z ZAIR'Y?UB+ M6&80'A+UQ9!.N#MKD=^_1GYXV.<3)LDEFY*N/Z&>_O*0!-1!O](6;:X M=TB '](7+4*CT#\$JCC\)IG)X3)P*0P*%I.5 Q^VT* F(@_<\=AGOX,72ZU M3=6HW(9=]) .TJ+QJ40\BFH'XMTZF3#/@?_#,Y>.2H2#6^*W-T;-W"\=#ZDK MV5$E-]ZFXW<\X-JL#1,(ZIX#BVX_L5EVGH/2L0G_FO7]>F-_:;(WZILL:N#, M&8HLD_",%K(EE58# $2YL-9810,H048B7V7PMZ6X&2W>^Y+DD\!EP%4]0VY4 M]2S]2.A'Y=M;,9X*\@3/M)$I+--'[N 70\X$4<"Q0M?=/O^4QWWQ982M :]W_N7R&T%;Q?7UH/U%Y1CL:.A[N^2T3:KF7KUY'V!>D! FC1MZH$7G MM831]Y2PLR_="[*9 I6Q%,E;,LQEW2&Y6 M$D]+ -$OJDQVS,&XE5([X@ MUMZ.\VYK&07OSV1(V V\2(1J9LZ[UKWT59<(4#?#E@,C3J#3V*&S&0S+O")] MOE)Q1T>'(YE@L:J@/ D$=X$ANP1GV$3''V0F=XGZ>I=(&'NXK)8+]/5RU_D#U>D#:U&4C+K',%EY" M2T8FFCKPX9X3"L8@^85$.&!1R&V0TW//+A=KQ19,RD[GEH(%1 SSIE_#@N1V!I(62! M\&]0N?..7)LO,$2^@%!!K0_TL'=;ESW;OI.Q9GN6#CZ82Z<0$=QANI!JE=#9 MB''U5\8M\N6,NPQ>"18<*>8H*)1>9FM6D^,A=>U6>)"WUZ>QZ7^FRE(4LL MT5Z^6<<8T&K6:_?C"?P5ZN^KR7Q:GD-PHXP:IJ\^I(^"_!NR1^EPE==F0Y@? M$'2(Q7C6/&=#KE ? M,?\S;O,LBE7U[!XM@-O(&_.H*NJ,!_;47D06N9*Y(,G?*D^<4CYAMK,HRE MY"$5>DC18%KO?:E>6J4 S\,_4DZX%X\WFI9>)+$^2$AQ8GC""9E_. @_@R@I7+FWE"/TS75Q7N:U!]! MHA[.QBL?*.O^/P_R:5M35V.M1O-@?^/(=!-]S#JD+2GC3DP*+&$%(+@V#ZA+ MV"VSHY#?8&4++#*3W^AMMX4 (IX*K70RAW0A]&J&"41!F!]S1SH9+ *AI\'9>NRQ3)^15:Z](N=YM M:)<_^R!S5PC[8I9IX0X :!C-6K$7>/$+7Y=^2$Z"P 7-!,G>VC+DSAGT MA#Q25\N%\G#P2+7Q 7$;$KTJ">8$71=QJ4R6XUYKYL]"%G.SM,?,OE8KSS2 MP 4\"Y83!OXM&3#7GR*_L1&E@C2,3V2H=L82+L'PA,QS0 Y"'T1A$KDA]9@? M28CJ)&0& QA,<4QX9>N[ MJ_]#,XB<_"CAY1[F3)CCW*Y>52CRRTOEKF3LQOIL=HD>"TGA8OJRECP/B8@' MON\.*' 3T+W-NH._! ]!@+"B$7EQ+BFS:\X-Y$?SH%X_W*P('%,HWK[Z?2D4 M(P6DR6)%@LR>DVX$,E6O[L5"O[#G [=Z[%@'I'W6)=6:68:.[^Y57_VYA*?G M@Y\$BGFC"S!7,*F;E9SF,Y2<.4;@8S1*RV)CU:EA53.2D]LBE,I-W2SKGJ^B MLRPZ5X*AS<&-UFK?'OHP\64XS :D-=R_]^Q$"# S[ QJ:ZV057>,ZL[@W?T$ M2O=]%:FU(G4N9<3$"L&R?@K!JC&COF/?3[#BOJL%ZV5D_7EK/_?X.@QF @+I MH&AKJE+0."P&VCV?*'@#>FGA5O%R=E^.$O; 'B-%@Q]PE^-^[0[*F1%JO;Z44UL<39LCP#K7'I WIM?SF:J_U6X:MRV\_ M#KVJVRD=]@5%2;SGFMF3@-";30:^N_.0VNLV&%7;CF!?QOLO$T^P38Z!8?UK MS$&_NJGUO;/P_$N!E;FKC+X5V[%1-3;V0#.K.E 6)QNC5$O'&,\ D7JA;U\O M+XT%5) ;ZD:,_(]9-DV+!'C,<*QVSCV=]-]%\*T8GXT('MLI;2NRU*Z5CO\Z MO^Q_VTZWQZ/D-JQ#'V*;AT3D>!9\>:4U$>W$T"QL7*_62V"+I$._+I* 8&P18R:62.&S(/;VS7E>]S#VR?,QI?KJI1G80SX-#5?E*.G.U)S_ M/?FX(*$3C.K J!:,571D*AT4DXWY>YEARR]C84F%R/EI.RN8\ZCIKUZI3Z;Z MJ&9JZXFR:K>W+O-]CN3/J\_P#H7 E=I"[>)+RR%CT!WF0@((NN/Y*AV,)%.] M@$OQH@O>?,-5BJB/R"._U%SN#">?T!.M BV V7\!YH)/5LK"Y26]T M@IWQ+A*'"D?JY19G52Y:VZ%I+II5M3)).?NT%"[@HXT9TOO2U<5UY:WE;WLKCR8C, Z 7=6;>^F-;.C5P*^@C\&6+L-[]YA.*TDO M<'E(=C*!HMIR\$Z%(S2)'-5$>_%$*FR+#RPG1\1AEG1W@MJ6D!PIT("FU^J M:12,>]\_V'LU*&L-RMXS,RCIE57*B)P@P5VFS$CNP"$&7A]F+IV"SV[K: DD M6I^T)WC4_M7(P,0G&'9">*KW#B4W.R"ET&; U#[FH=O^,4.MG!07 +9=4\ MC+,2]60=OM-!\D(*"9'P/+:=G[?!B>-;'TQ]Z\,NH2&A^@ YL'/"F(JE008D MFK>Q=B-@=5RGZ&6%VQP>Z^!0YE\<82Z D7Y!QP\^6%6 I=)<%%#J1UQ0R $)..,%TA-%&LW%NINLU?\0OIHCK&4'>9VHWO MD#8:Q*%.O98T5/%0?<8V3)BFP(!D>RUXI'#*&*0^!O@T8T\-K#]7]W:U_,C( M'L Z?X42:]:"#!A0(>[FQWWI!]H9 Y"5MBC%,"+@"O MX;(:+Z2<46@KOJ2*U"A0)&"/!]F-K;0&B -DT[L4Y5JISXI;09B2"MYZ-N#F M[,"7@*D:6.L )N #^GJCVT_^R=7Z6[U9L'M4;UE.R9UL\A MI /:)BOXU7 ME6JUP",D( Q8%!(.WDP[GQ6-DTRW(*00@]1;5FNO28+RI$PZ%)?1/!4\9=Q= MC'].O3KIA-@YT:R7+ \GH2Z9Y1#?G1N$N5,M . &1'W26#2$L?=%6^T4Z#6 1T[O-39U\F5\+'0 U\ M*]88E2'1@7("X@2L6.*_8R^+,5-*@AQ>"*Y*GZ( [9,^'Y'=10[98VJM-/(J M6@/IL]DJ@EKF;Q#=>UP53!6].$[A^2% X Z_TN]"+5,&S3M]7N0#D#S!QAM M_LJ5RBXQ)>XMAD$P]V(D=*BQN(' )(X4BZ#+L@5($@(FB)QV5I$'L9DVX6HL M=LN$S>5*5',\5B/X@2Y^*"] !0:9$"H#&:=8H8._\5F ^"#*? 9%4OF2U;2M M_"T(*TBN%K^^NE\>^/<[G02'\ BOI68J7493"SAV]B@2LQ]] 57B8_?26-J,A#^ M-;K> ?6NY_=$Z!GU?5AH\M_A\3&UVI!6>5!'Z353BD_5"H .5%8Z%!H'6/ Q ME\F T"+0[FP>>N!$U WC4Q\*3]T[E5S0&JRV4V5N<(>-.4<$'($> 0PA @ M.PO"Q+;$12L5"*[T@WX$Q(:Q(U>-3K.@$'_J*>Z2H=#X@US$5N[27_IR;N%B M&\OQ'(#GQ8LGJ3N]GQ1HR!2OIJA],*RZ@=G5C &F,70DR[!I*/!^>4:=M!^: M?IW8%%IZA-7E+$IRH"6$7[#6]]5Y(\%&/C+;89 H\R#K8N8AC^/#Y"BZ0214 M-4('YFK5#7(X)=Y@%;Y&,%WV3CGD' 1NLWP],I;3803\4O=Z+\X'":;:I 1# MZI"1X@KWF ] 76)X?T M+%VI5LF-#B)U=4ZIP,^Q0K-T/A<\=4( \LP/11>8X>38)TM01& ?\S5/2W >H] MYHUGS =HO. M6#B1.R,VC:1:C> -^TWLZJR4"1D%_ MMA:M= T'N_-G:=:>[,W!M3H.R$ZXME?]8+G;XX+P8=9:,S^Y7VY?.J[("FD+ MRD>D4R9G@DJ\DWJ+9,,3G/A#7\=+0/'CK0*FCDXKR*X$D^IG4U46TAYSAB?= MD\M9OZC+68O@W7:5.G:IGT]Z?6,>(11&,(\:F21 P(<8??R)X^/_ E!+ 0(4 M Q0 ( )R&DUBLU@#EW@< -DI - " 0 !E>%\V M-34X,# N:'1M4$L! A0#% @ G(:36%B0#[]F P ;@T !$ M ( !"0@ '=I;G0M,C R-# T,3DN>'-D4$L! A0#% @ G(:36'@G MKMCS! 8RX !4 ( !G@L '=I;G0M,C R-# T,3E?9&5F M+GAM;%!+ 0(4 Q0 ( )R&DUCP!F&O( 8 &$^ 5 " M <00 !W:6YT+3(P,C0P-#$Y7VQA8BYX;6Q02P$"% ,4 " " &UL4$L! A0#% @ G(:36*/ZU;)W% GG\ !, ( ! MUQL '=I;G0R,#(T,#0Q-U\X:RYH=&U02P4& 8 !@"$ 0 ?S end